Rita I. Jain's most recent trade in First Tracks Biotherapeutics Inc. was a trade of 16,510 Stock Option (right to buy) done . Disclosure was reported to the exchange on April 20, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| First Tracks Biotherapeutics | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 16,510 | 16,510 | - | - | Stock Option (right to buy) | |
| First Tracks Biotherapeutics | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 16,510 | 16,510 | - | - | Stock Option (right to buy) | |
| First Tracks Biotherapeutics | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 10,600 | 10,600 | - | - | Stock Option (right to buy) | |
| First Tracks Biotherapeutics | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 8,015 | 8,015 | - | - | Stock Option (right to buy) | |
| First Tracks Biotherapeutics | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 6,030 | 6,030 | - | - | Restricted Stock Unit | |
| First Tracks Biotherapeutics | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 5,500 | 5,500 | - | - | Stock Option (right to buy) | |
| First Tracks Biotherapeutics | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 4,000 | 4,000 | - | - | Restricted Stock Unit | |
| First Tracks Biotherapeutics | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2026 | 1,300 | 1,300 | - | - | Restricted Stock Unit | |
| Avalo Therapeutics Inc | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2026 | 1,339 | 1,339 | - | - | Stock Option (Right to Buy) | |
| AnaptysBio Inc | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 5,500 | 5,500 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2026 | 4,000 | 4,000 | - | - | Restricted Stock Unit | |
| SAB Biotherapeutics Inc | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2026 | 240,000 | 240,000 | - | - | Stock Option (right to buy) | |
| Avalo Therapeutics Inc | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 1,043 | 1,043 | - | - | Stock Option (Right to Buy) | |
| Avalo Therapeutics Inc | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2025 | 1,572 | 1,572 | - | - | Stock Option (Right to Buy) | |
| Avalo Therapeutics Inc | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 40,200 | 40,200 | - | - | Stock Option (Right to Buy) | |
| AnaptysBio Inc | Rita I. Jain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2025 | 7,330 | 11,864 (0%) | 0% | 0 | Common Stock | |
| AnaptysBio Inc | Rita I. Jain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2025 | 6,030 | 0 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Rita I. Jain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2025 | 1,300 | 1,300 | - | - | Restricted Stock Unit | |
| Celldex Therapeutics Inc | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 16,500 | 16,500 | - | - | Non-Qualified Stock Option (right to buy) | |
| AnaptysBio Inc | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 16,510 | 16,510 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2025 | 6,030 | 6,030 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Rita I. Jain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 4,534 | 4,534 (0%) | 0% | 0 | Common Stock | |
| AnaptysBio Inc | Rita I. Jain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 3,234 | 0 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Rita I. Jain | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2024 | 1,300 | 0 | - | - | Restricted Stock Unit | |
| Celldex Therapeutics Inc | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 16,500 | 16,500 | - | - | Non-Qualified Stock Option (right to buy) | |
| AnaptysBio Inc | Jain Rita I. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 16,510 | 16,510 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | I. Rita Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2024 | 6,030 | 6,030 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 10,600 | 10,600 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 8,015 | 8,015 | - | - | Stock Option (right to buy) | |
| AnaptysBio Inc | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 3,900 | 3,900 | - | - | Restricted Stock Unit | |
| AnaptysBio Inc | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 3,234 | 3,234 | - | - | Restricted Stock Unit | |
| Celldex Therapeutics Inc | Rita I. Jain | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 17,100 | 17,100 | - | - | Non-Qualified Stock Option (right to buy) |